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RESEARCH ARTICLE
A random forest based biomarker discovery 
and power analysis framework for diagnostics 
research
Animesh Acharjee1,2,3*† , Joseph Larkman1,2†, Yuanwei Xu1,2, Victor Roth Cardoso1,2,4 
and Georgios V. Gkoutos1,2,3,4,5,6
Abstract 
Background: Biomarker identification is one of the major and important goal of functional genomics and transla-
tional medicine studies. Large scale –omics data are increasingly being accumulated and can provide vital means 
for the identification of biomarkers for the early diagnosis of complex disease and/or for advanced patient/diseases 
stratification. These tasks are clearly interlinked, and it is essential that an unbiased and stable methodology is applied 
in order to address them. Although, recently, many, primarily machine learning based, biomarker identification 
approaches have been developed, the exploration of potential associations between biomarker identification and the 
design of future experiments remains a challenge.
Methods: In this study, using both simulated and published experimentally derived datasets, we assessed the 
performance of several state-of-the-art Random Forest (RF) based decision approaches, namely the Boruta method, 
the permutation based feature selection without correction method, the permutation based feature selection with 
correction method, and the backward elimination based feature selection method. Moreover, we conducted a power 
analysis to estimate the number of samples required for potential future studies.
Results: We present a number of different RF based stable feature selection methods and compare their perfor-
mances using simulated, as well as published, experimentally derived, datasets. Across all of the scenarios considered, 
we found the Boruta method to be the most stable methodology, whilst the Permutation (Raw) approach offered 
the largest number of relevant features, when allowed to stabilise over a number of iterations. Finally, we developed 
and made available a web interface (https ://joela rkman .shiny apps.io/Power Tools /) to streamline power calculations 
thereby aiding the design of potential future studies within a translational medicine context.
Conclusions: We developed a RF-based biomarker discovery framework and provide a web interface for our frame-
work, termed PowerTools, that caters the design of appropriate and cost-effective subsequent future omics study.
Keywords: Random forest, Feature selection, Power study, Biomarker
© The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which 
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the 
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or 
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line 
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory 
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this 
licence, visit http://creat iveco mmons .org/licen ses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creat iveco 
mmons .org/publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Background
Over the last few years there has been lots of emphasis 
on the high dimensional omics data generation, includ-
ing untargeted –omics datasets, like transcriptomics [1, 
2] metabolomics [3, 4], proteomics [5, 6], microbiomes 
[7–9], as well as deep phenotyping [10]. As a conse-
quence, large amount of data is routinely being accumu-
lated, which needs to be integrated and analysed so as 
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to facilitate the identification of relevant markers. If the 
biomarkers identified from the different-omics datasets 
are robust, reproducible and indicative, then they can be 
potentially useful for patient/disease stratification [11, 12] 
and can also provide powerful clinical relevant insights as 
diagnostic or prognostic tools. Selecting relevant mark-
ers or features from high dimensional datasets is defined 
as feature or variable selection [13] and requires a robust 
statistical or computational workflow [14].
The application of machine learning methods for fea-
ture selection is a well-established approach [14]. Lately, 
decision tree based statistical machine learning meth-
ods, for example, Random Forest (RF) [15], have gained 
prominence. RF is an ensemble learning method, which 
has been applied successfully on multiple high dimen-
sional omics studies including transcriptomics [16], 
metabolomics [17], methylation [18] and proteomics 
[19]. The objective of these studies has been either the 
prediction or the selection of important features that 
can serve as potential biomarkers and that can be poten-
tially employed for patient stratification. The random 
forest algorithm is a powerful prediction method that is 
known to be able to capture complex dependency pat-
terns between the outcome and the covariates. The latter 
feature renders random forest a promising candidate for 
developing prediction methods tailored to the challenges 
multi-omics data analysis entails.
In the case of omics analysis, it is important to employ 
feature selection procedures that are systematic and data 
driven so to avoid any bias selection. RF, coupled with 
other feature selection methods, has successfully been 
applied for such tasks, for example, in studies related to 
the selection of genes and metabolites [20] and the selec-
tion of lipids and metabolites [21]. More recently, Degen-
hardt et  al. [26] performed a simulation study as well 
as applied a number of different RF-based method on 
publicly available experimental datasets. However, their 
results, due to the lack of an assessment and validation of 
the effect/weight of the identified markers, have limited 
value within the context of a ‘study design’ or a ‘power 
analysis’ for potential future translation research stud-
ies. Other studies have focused on these aspects using 
metabolomics [22, 23] and transcriptomics datasets [24], 
however, these approaches are tailored made to specific 
-omics types and often fail to properly relate, using stable 
feature selection procedures, to power calculations for 
identified putative biomarkers.
In this study, we have performed an extensive simula-
tion using RF based feature selection methods, namely 
the Boruta [25], the permutation based feature selection 
[26], the permutation based feature selection with cor-
rection [26], and the backward elimination based fea-
ture selection [27] methods, both in a regression and 
classification context, so as to assess their feature selec-
tion and prediction error abilities. We further assessed 
the performance of these methods over experimentally 
derived datasets in an effort to understand their perfor-
mance over disparate -omics dataset paradigms. We also 
developed a workflow to identify the number of samples 
required for a future study using the stable biomarkers 
that were identified in the first task. Finally, we developed 
a web interface, termed PowerTools, to streamline power 
calculations, encompassed by our approach, offering the 
potential for designing appropriate and cost-effective 
subsequent future omics study designs.
Methods
Random forest (RF)
Random Forest (RF) [15] is an ensemble-based machine 
learning (ML) method, based on a decision tree algo-
rithm, that can be used for both classification as well as 
regression based analysis. Typically, around two-thirds 
of a particular study samples are used for the model fit-
ting or training while the remaining one-third is used for 
model testing, termed as the out-of-bag (OOB) samples. 
OOB is used to quantify the model performance. For the 
case of classification, the prediction performance can be 
quantified in terms of the rate at which OOB samples are 
misclassified across multiple classes or the OOB error. 
For the case of regression, the average distance between 
OOB predictions and the true continuous response 
variable can be quantified using the mean squared error 
(MSE) metric. The contribution from each variable to 
the final model is quantified as a ranked measure of vari-
able importance (detailed information is provided in the 
methods sections in Additional file 1).
RF feature selection methods
Four methods, namely, the Boruta [25], the permuta-
tion based feature selection [26], the permutation based 
feature selection with correction [26], and the backward 
elimination based feature selection [27] methods, were 
applied so as to automatically select important features 
from the aforementioned ranked list RF generates. The 
details of the statistical basis of each of these approaches 
is outlined in the following section.
Boruta
Boruta [25] compares the feature importance values 
estimated for the real predictor variables, against the 
variables generated by the permutation of these variables 
across observations. Variables, generated by permuta-
tion, are termed “shadow” variables. For each run, a RF 
is trained using a double length set of predictor variables 
comprised of an equal number of true and shadow vari-
ables. For each of the real predictor variables, a statistical 
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test is conducted comparing its importance in relation to 
the maximum importance value achieved by a shadow 
variable. Variables with significantly larger or smaller 
importance values are defined by the algorithm as impor-
tant or unimportant, respectively. In subsequent runs, all 
unimportant and shadow variables are removed, and the 
process is repeated until all variables have been classified 
or a specified maximum number of runs is reached.
Permutation based feature selection
Permutation testing is an established approach for 
approximating a significance level or threshold for the 
selection of a subset of associated features derived from 
a RF model [21, 26]. While RF quantifies the importance 
of the features that explain the variation present in the 
outcome variable (either quantitative or binary), it fails 
to provide a significance label for the selected features. 
The aim of including permutation within the RF model 
was to automatically select features based on the signif-
icance label estimated from the input data. We permu-
tated the outcome variable (either quantitative or binary) 
separately and applied a RF model for each case. The RF 
model was applied 1000 times over 1000 different out-
come variable randomizations and for each analysis we 
estimated the variance or class error explained by the RF 
model and compared with the true distribution. [21, 45, 
21] provides the details of the methodology adopted.
Finally, permutation testing was implemented using 
both raw (uncorrected) p-values, as well corrected ones, 
for multiple hypothesis testing using the Benjamini–
Hochberg procedure (corrected) [28]. For both imple-
mentations, a threshold p-value of 0.05 was used to 
determine statistical significance.
Recursive feature elimination
Recursive feature elimination (RFE) [27] forms an 
approach aiming to determine the smallest subset of 
variables that produce an effective model with a good 
prediction accuracy. The methodology it adopts involves 
the iterative fitting of RF, where upon each iteration, a 
specified proportion of variables, with the smallest vari-
able importance, is discarded. This process is applied 
recursively until only a single variable remains available 
as input. At each iteration, the model performance is 
assessed in terms of the out-of-bag error, when RF is used 
in a classification capacity, or mean squared error (MSE) 
for regression forests. The set of variables, leading to 
the generation of the smallest, or one within a specified 
minimum range, RF error, are ultimately selected. In this 
study, we used the R package varSelRF [27] for the imple-
mentation of this method. Moreover, we modified the 
constituent functions of varSelRF to accept a continuous 
y variable input and used MSE for the model assessment 
so as to facilitate the feature selection when RF is used in 
a regression capacity.
Statistical analysis
Module 1: stable feature selection
We divided our analysis approach into two modules. 
Module one incorporates a nested cross validation (CV) 
procedure [29–32], which is summarised in Fig. 1 (Mod-
ule 1). First, a training:testing ratio of 75:25 is used to 
generate the outer train and test data subsets. The whole 
process is repeated 100 times with multiple repeating 
folds. The outer train subset is then subject to a further 
tenfold CV, where one-tenth of the data (inner train) is 
used for the hyper parameter optimisation (additional 
information is provided in the methods section in the 
Additional file 1). The remaining nine-tenth of the data, 
forming the inner test subset, is then used for the appli-
cation of 100 iterations of feature selection. For each 
iteration, a RF is trained and each of the aforementioned 
methods is applied to identify a subset of important fea-
tures. Stable features are then defined as those identified 
by a particular method following a number of iterations 
greater than a specified stringency value. In the present 
study, features, selected in > 5/100 iterations, are deter-
mined low stringency (LS) stable features and ones, 
selected following a minimum of 90/100 iterations, are 
considered high stringency (HS) stable features. The 
entire procedure is repeated four times, each time using a 
modified outer loop split, such that each sample appears 
once within the outer test data subset. The values of each 
feature, selected by each method, specifying the predic-
tive power, the prediction error, and the frequency, are 
then averaged across the four outer loop repeats. The full 
nested CV procedure was applied to simulated data as 
well as three published experimentally derived datasets. 
Due to sample size limitations, CV was not conducted for 
one of the selected experimentally derived datasets.
Module 2: power analysis
We implemented a flexible approach to facilitate the 
power analysis and to determine the sample size, based 
on the functions designed and described by Blaise et al., 
[23]. We included both datasets with a continuous out-
come variable (regression) as well as ones with a two-
group (binary) classification outcome. Furthermore, 
the correlation structure of the input data was explic-
itly modelled, in order to capture any multicollinearity 
between variables. An overview of the approach is repre-
sented schematically in Fig. 1 (Module 2) and described 
briefly in the following section. (detailed information is 
provided in the methods section in the Additional file 1).
The synthetic data was first generated using a mul-
tivariate log-normal distribution, namely the R library 
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MASS ‘mvrnorm’ function. From the resulted simulated 
datasets, a subset of the data was considered contain-
ing a specified series of sample sizes (for example: 5, 
10, 15, 50, 100 etc.). In the case of regression, for each 
of the variables assessed, a continuous outcome is gen-
erated that relates the assessed variable with a Pearson 
correlation value equal to that of its relation to the real 
outcome (effect size). The simulated outcome variable is 
then regressed against each variable to produce a set of 
p-values describing each variable’s association with the 
outcome.
For the two-group (binary) classification case, two 
datasets are produced for each specified sample size (one 
for each group) and a specified Cohens d effect size [33] 
is introduced to one of them and its highly correlated 
partners. A one-way ANOVA is then conducted for each 
variable, comparing the intra and inter group variances, 
and producing a set of p-values describing the variables 
with statistically significant variances.
In either case, true/false positive metrics are then 
determined by comparing the set of statistically signifi-
cant variables to a set containing the variable chosen for 
analysis and its highly correlated partners.
Furthermore, the R implementation of the PowerTools 
builds upon the functionality of the original functions 
in a bifold manner. First, each variable is automatically 
assessed using its true effect size; in the case of regres-
sion, the true effect size of a variable is estimated 
according to its correlation with the true outcome vari-
able, whilst for a two-group classification, the observed 
Cohen’s d effect size is computed. Second, highly corre-
lated variables can be optionally grouped together and 
only the member of each group, with the largest effect 
size, is used as a representative group member thereby 
Fig. 1 Schematic diagram of the simulation set up and the published experimentally derived (real) data analysis
Page 5 of 14Acharjee et al. BMC Med Genomics          (2020) 13:178  
facilitating the identification of a smaller subset of poten-
tial biomarkers.
Dataset description
We used simulated data, as well as published experimen-
tally derived datasets. Table 1 provides a detailed descrip-
tion of these datasets. The data simulation was performed 
based on the uniform as well as the normal distribution.
Uniform distribution‑based data simulation
Simulation data, featuring correlated predictor variables 
and a quantitative outcome variable, were generated 
using a nonlinear regression model, according to previ-
ously reported methods [26, 34]. Specifically, the simu-
lation strategy and its associated equations, outlined by 
Degenhardt et  al., [26] , was adapted and implemented, 
with minor parameter modifications. A single simulation 
scheme was incorporated and sixty (six groups of ten) 
correlated variables were generated, alongside additional 
uncorrelated variables, to produce a dataset of 5000 pre-
dictor variables.
First, six uniformly distributed variables, x1, x2, x3, x4, x5 
and x6 , were sampled individually from U(0, 1) . The cor-
related predictor variables were then generated according 
to the equation:
 for j = 1, ..., 10 and i = 1, ..., 6 , where V (j)i  denotes the jth 
variable in group i and the correlation between V (j)i  and x 
decreases as j increases. Conversely, values for the uncor-
related predictor variables were simply sampled from the 
uniform distribution U(0, 1).
The variables x1, x2 and x3 were also used to gener-













· N (0, 0.3)
 where y correlates decreasingly with variables x1, x2 and 
x3.
The simulation scheme, outlined above, was repeated 
iteratively so as to produce a final simulation data-
set consisting 200 observations, 5000 predictor vari-
ables and a quantitative outcome variable correlated 
with only the first three groups of correlated predic-
tor variables. Additionally, the quantitative outcome 
variable was adapted for a binary classification context, 
whereby observations with a ‘y’ value, below the mean 
of the outcome variable set, was assigned to group one, 
while observations, associated with a ‘y’ value above 
the mean, were assigned to group two. Consequently, 
the same simulation protocol was used to facilitate the 
assessment of feature selection and power analysis in 
both a classification and regression context.
Normal distribution‑based data simulation
Six variables x_i(i = 1…6) were sampled from the stand-
ard normal distribution and the outcome variable ‘y’ 
was calculated according to Eq. 2. The median was used 
as a cut-off value for the class labels so as to obtain a 
more balanced assignment of classes.
Publicly available datasets
A summary of the published, experimentally derived 
datasets is presented in Table 1.
Software and code availability
We used the R (https ://www.r-proje ct.org) v3.5.0 soft-
ware for statistical computing. Different packages were 
used for the RF methods, listed in Table  2. The web 
interface was developed using the R shiny app (http://




1+ exp(−20(x2 − 0.5))
+ 3x3 + N (0, 0.2)
Table 1 A list of the published datasets used in this study
For each of the RF models, two datasets was considered and the model outcome was compared with the published results






Outcome variable Pubmed ID References
Regression Metabolomics 73 196 Relative liver weight 28,185,575 [21]
Lipidomics 40 219 infant milk amount 28,190,990 [35]
Classification Metabolomics 73 196 Relative liver weight class (below or above the mean value) 28,185,575 [21]
Transcriptomics 68 414 Colorectal cancer (CRC) stages 27,176,004 [36]
Transcriptomics 20 1386 Primary Sclerosing Cholangitis (PSC) vs. Ulcerative colitis (UC) 32,016,358 [37]
Transcriptomics 40 25,697 OB/OB vs. wild type genotype mouse 32,646,215 [38]
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rkman .shiny apps.io/Power Tools /. All other scripts are 
have been made freely available in our github reposi-
tory: https ://githu b.com/joela rkman /RF-Featu reSel 
ectio n-Power Analy sis.
Results
Regression mode
Data simulations were performed using two different 
types of distribution, namely a uniform and a random 
normal distribution.
Table 2 List of the methods and R packages used
Method R package used References
Random Forest randomForest [15]
Random Forest (Optimised for memory) ranger [39]
Boruta Boruta [25]
Hyperparameter selection Caret [40]
Permutation based feature selection pomona [26]
Recursive feature elimination (RFE) vaSelRF [27]
Fig. 2 Results from the simulation study in RF regression mode. a The structure of the simulated predictor data from uniform distribution and 
the association with outcome variable (y) is described. Only V1-V120 are shown of full dataset featuring 5000 variables. b The number of features 
stably selected by each approach in at least 5/100 iterations (Low Stringency) or a minimum of 90/100 iterations (High Stringency) are shown. True 
positive: V1–V30, False positive: V3–V5000. Values describing the number of times each feature is chosen by a particular approach are averaged 
across those achieved after 100 iterations for each of the four inner loop test datasets. c The variance in predictive accuracy (R-Squared), across 
all four outer loop cross-validation repeats, is shown for RFs trained using only the high or LS stable features selected by each feature selection 
approach using the relevant inner loop test dataset
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Simulation data
We performed a regression analysis considering 5000 
predictor variables and a continuous response (y). Fig-
ure  2a illustrates a correlation plot of the first 120 fea-
tures’ relationships, depicting the intra-group correlation 
for each of the predictor variables as well as the correla-
tion between each feature and outcome variable (y). The 
first sixty variables formed six highly correlated clusters, 
whilst the remaining features showed no pattern of cor-
relation between variables. The first three correlated 
groups exhibited a clear correlation with the outcome 
variable that decreased in intensity both within and 
between correlated groups, from V1–V30. All other pre-
dictor variables exhibited a negligible correlation with 
the continuous outcome variable.
The results of RF in regression mode over simulated 
data are summarised in Fig. 2b, where the feature selec-
tion is considered in terms of both HS and LS for stabil-
ity. In the HS environment, both the Boruta and the RFE 
methods identified V1–V20, the Permutation (Corrected) 
method identified V1–V21 and finally the Permutation 
(Raw) method identified V1–V29. In the LS environ-
ment, 29 true positive features (V1–V29) were identified 
by the Boruta, the RFE and the Permutation (Corrected) 
methods.
Following the stable feature identification, selected by 
each method, the performance of the validation models, 
trained using only these features and held out data, were 
quantified in terms of predictive accuracy (R-squared). 
The results of this analysis are shown in Fig. 2c, depicting 
the predictive performance varying negligibly between 
the models.
We conducted a power analysis using a subset of the 
simulation data containing only the six groups of cor-
related features (V1–V60) and a single non-correlated 
variable (V4500). The results from this analysis are pre-
sented in the Additional file 1, SF2(A), where the groups, 
containing the 20 Boruta HS stable features are indi-
cated with an asterisk. The six correlated feature groups 
were successfully detected by the function and grouped 
together. Each of the group members, with the largest 
effect size, was then assessed for power, across a broad 
range of sample sizes, using the continuous outcome 
variable scheme outlined in Module 2 We compared the 
features, representing the three groups used to generate y 
(V1–30), in terms of their effect and sample sizes neces-
sary to achieve maximal power. V1, chosen to represent 
the first correlated group (V1–V10), had an effect size of 
0.82, and achieved a power = 1 with a sample size of ~ 60; 
the second y, related the second group (V11–V20), was 
represented by V19 and had an effect size of 0.49 achiev-
ing a power = 1 with ~ 140 samples; whilst the third 
group (V21–30), represented by V21, had an effect size of 
0.38 and achieved a power = 1 with a sample size of ~ 225.
The assessment of the power calculations for the non-
y-related features revealed similarly negligible effect sizes 
for V36 (representing the correlated group 3) and V4500. 
Consequently, the power values calculated for these vari-
ables retained a close to zero value across the full range of 
the considered sample sizes. Contrastingly, V50 and V52 
(representing the correlated groups 5 and 6, respectively) 
each produced an effect size 0.14. Consequently, signifi-
cant power values could be obtained for these variables 
at sufficiently large sample sizes. We determined that a 
sample size of ~ 1990 is necessary to observe power = 1.
The normal distribution results are detailed in the 
Additional file  1 (SF12). In summary, out of 40 itera-
tions, no features, with a frequency greater than 24, were 
selected by RFE. In contrast, the Boruta method identi-
fied the features V1-V10 with a frequency of at least 30 
(Additional file 1, SF12). The  R2 (% variation explained), 
using the common stable features, was 98.22%. A list of 
the  R2 values across the other methods and data sets is 
provided with the Additional file 1 (Table 1).
Dataset 1: metabolomics
A similar approach was applied on a publicly available 
–omics dataset [21] that features lipid metabolites (Posi-
tive DI-MS Lipids) and employs a relative liver weight as 
a continuous outcome variable (y). Acharjee et  al.,[21] 
identified six metabolites of interest which we considered 
as known in this study.
The application of the Boruta method resulted in the 
selection of the largest number of HS features, including 
three previously known features of interest (Table 3 and 
Additional file  1, SF3A). In the LS environment, using 
the Boruta method, we were able to select 40 additional 
features. In addition, the HS Boruta model achieved the 
highest R-squared value, slightly exceeding the value 
it achieved under LS (Fig.  3a). The Permutation (Raw) 
method resulted in a strong stability across iterations 
(Table  3), exhibiting consistent predictive performance 
(R-squared) across validation models (Fig. 3a), and allow-
ing for the identification of two known metabolites under 
HS. The application of both the RFE and the Permutation 
(Corrected) methods exhibited poor stability across iter-
ations, retaining only six and three HS features, respec-
tively, despite the methods identifying 94 and 51 features 
each, under LS (Table 3).
The Dataset 1 power analysis results are presented in 
Fig. 3b. PowerTools reduced the 46 HS Boruta features 
to seven highly correlated groups, and subsequently 
power calculations were performed for the group mem-
ber with the largest observed effect size. Five potential 
biomarkers, with an effect size in excess of 0.6, emerged 
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from this analysis, for which the maximal power values 
were observed at a sample size between 35 and 45. The 
two remaining features obtained effect sizes of 0.4 and 
0.27 and achieved a maximum power at a sample size of 
75 and 620, respectively. The relationship between each 
of the assessed variables and the continuous outcome 
variable are displayed in Fig.  4a. All seven variables 
were deemed statistically significant (P-value < 0.05), 
whilst adjusted R-squared values ranged from 0.77 
Table 3 List of the methods, stringency (high and low) and evaluation criteria used for both regression and classification
Evaluation criteria are formed by the number of the features identified by each method vs. the known features that are already reported or simulated in the model
RF methods Stringency Criteria Regression Classification
Simulation Metabolomics Lipidomics Simulation Lipidomics Transcriptomics-1
RFE High TP/Known 20 1 1 10 0 –
FP/Novel 0 5 0 0 0 0
Low TP/Known 29 3 3 29 2 –
FP/Novel 19 91 8 201 18 14
Boruta High TP/Known 20 3 2 11 2 –
FP/Novel 0 43 6 0 24 19
Low TP/Known 29 3 3 29 3 –
FP/Novel 1 83 34 9 10 39
Permutation (Raw) High TP/Known 29 2 2 19 2 –
FP/Novel 0 24 7 0 10 0
Low TP/Known 29 3 3 29 3 –
FP/Novel 98 68 47 465 35 132
Permutation (Corrected) High TP/Known 21 2 1 11 2 –
FP/Novel 0 1 0 0 6 0
Low TP/Known 29 3 3 29 3 –
FP/Novel 8 48 26 110 46 66
Fig. 3 Validation model performance and power analysis of published experimentally derived data 1, regression mode. a Boxplots displaying the 
variance in the observed R-squared value of validation models trained using the stable features selected by each feature selection approach, across 
four outer-loop CV repeats. Values are shown for models trained using either the features selected by each approach in at least 5/100 iterations 
(Low Stringency) or a minimum of 90/100 iterations (High Stringency). b The three groups of correlated features identified by the power function 
are represented by the group member with the largest observed effect size. The effect size of each assessed variable is shown along the y axis and 
a series of sample sizes along the x axis. Power values determined for each effect/sample size combination using a simulated dataset with the same 
correlation structure as input data and displayed using variably sized/coloured rhombi
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for ‘SM(39:7)’ to just 0.06 for ‘PC(33:2) or PE(36:2). 
The three previously known metabolites identified 
by the Boruta method, namely ‘PE(42:4)’, ‘PC(40:5)’ 
and ‘PC(42:9)’, correlated highly with the putative bio-
marker with the largest effect size ‘SM(39:7)’.
Dataset 2: lipidomics
The results of the second application of the regression 
approach, using lipidomic data obtained from 3 months 
old infants, are summarised in Table  3 and the Addi-
tional file 1, SF3B). Previous work identified three lipids, 
namely PC(35:2), SM(36:2) and SM(39:1) [35], which 
were considered as known. These metabolites were iden-
tified by all of the four feature selection methods, within 
the LS environment, while the ‘SM(36:2)’ and ‘SM(39:1)’ 
metabolites were identified by the Boruta and the Per-
mutation (Raw) methods within the HS environment 
(Additional file 1, SF4A). The RFE and Permutation (Cor-
rected) methods failed to achieve stability over this data, 
retaining only but a single feature, namely ‘SM(39:1)’, 
within the HS environment. In total, eight features were 
selected by the Boruta method, which were used for the 
power analysis.
The power function produced three correlated groups, 
represented by each of the observed known metabolites 
(‘SM(36:2)’ and ‘SM(39:1)’), and the novel potential bio-
marker, namely ‘PC(34:2)’. The three features achieved 
effect sizes of 0.74, 0.66 and 0.68, respectively. The power 
calculations across all three groups had a similar per-
formance, achieving a maximal power between 35 and 
45 samples (Additional file  1, SF4B). The relationship 
between the three subset features and the outcome vari-
able is presented in Fig. 4b.
Classification mode
Simulation data
The simulated dataset was modified to produce a binary 
classification outcome variable (y) and were then uti-
lised for the feature selection (Table  3 and Additional 
file 1, SF5A). Within the HS environment, while all meth-
ods successfully identified all of the variables from the 
first group that were used to generate y (V1–V10), only 
a single variable from the second group (V11–V20) was 
identified by the Boruta and the Permutation (Corrected) 
methods and none of the variables were identified by 
RFE. Permutation (Raw) was the most successful method 
within the HS environment, identifying V11–V19 from 
the second group. No method identified any variables 
from the third group (V21–V30). Within the LS environ-
ment, the Boruta method exhibited the greatest stability, 
increasing its tally of true positive features to 29, while 
identifying only 9 false positive variables. The RFE, Per-
mutation (Raw) and Permutation (Corrected) methods 
also increased their true positive tally to 29, and identi-
fied 201, 465 and 110 false positive variables, respectively 
(Table 3).
We conducted a power analysis (Additional file  1, 
SF5(B)) using the eleven true positive features that were 
stably selected by the Boruta method within the HS envi-
ronment. The power function correctly identified two 
groups of features (V1-V10 and V11) and subsequently 
the Cohen’s d effect sizes for each variable was calculated. 
Several features were reported with equally large effect 
sizes and V2 was chosen at random to represent the first 
group. Both the V2 and V11 features exhibited effect sizes 
greater than the 0.8 threshold for a large effect defined by 
Cohen (1998)[33], with the value of 1.82 observed for V2 
and 0.88 for V13. Consequently, maximum power values 
Fig. 4 Results from public dataset identified by the module 1 of the workflow is listed above with probability values < 0.05. a Stable metabolic 
markers and their variance explained with relative liver weight is shown. b Lipids associated with amount of milk in the 3 m old infants are listed
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were achieved for both features when employing a sam-
ple size < 20.
The normal distribution simulation results are reported 
in the Additional file 1, SF13. In summary, we found that 
V1–V10 andV21–V30 were selected by all four meth-
ods with 100% frequency. Variables selected by the RFE 
method were also selected by the Boruta method, but not 
vice versa. The overall class error rate using the stable 
features were estimated to be 3%. The list of the classifi-
cation error across other methods and data sets are listed 
in the Additional file 1, Table 2).
Dataset 3: metabolomics
To further assess the classification approach’s perfor-
mance, we utilised the dataset resulting from Acharjee 
et al. (2016a, b [21], with a modified binary classification 
outcome variable, namely a below or above the mean 
relative liver weight value (Table 3 and Additional file 1, 
SF6A and SF6B). The application of the Boruta and Per-
mutation (Raw) methods resulted in the selection of a 
similar number of features in both the HS and LS envi-
ronments. Within the HS environment, both methods 
selected two, known, lipids and ~ 20 novel features of 
interest. Within the LS environment, the methods iden-
tified an additional known lipid alongside ~ 70 potential 
novel features.The RFE method identified comparatively 
few features within the LS environment and none within 
the HS one. Conversely, the application of the Permuta-
tion (Corrected) method resulted in the selection of eight 
HS features, more than double that the ones identified 
during the regression analysis. The 26 HS stable features, 
selected by the Boruta method, were used to conduct the 
power analysis. Two groups of correlated features were 
identified, namely ‘PC(32:0) or PE(35:0)’, with a Cohen’s d 
effect size of 1.92 and ‘PC-O(35:5) or PC-P(35:4)’, with an 
effect size of 2.24. These values exceed the Sawilowski’s 
descriptors of ‘very large’ and ‘huge’, respectively [41]. 
Maximum power values were achieved for each group at 
a sample size of ~ 10–20 (Additional file 1 SF6B).
Dataset 4: transcriptomics
Finally, we applied the binary classification approach 
to three different genomics cohorts. The first dataset 
features four healthy control samples as well as sam-
ples from stages 1–4 colorectal cancer (CRC). The 
analysis was conducted as a series of pairwise clas-
sifications aiming to identify the biomarkers that dis-
tinguished, most effectively, the healthy controls from 
samples at each CRC stage (Additional file  1, control 
vs stage 1 in Table  3 and other stages in SF7). Across 
all four pairwise comparisons, the application of the 
Boruta method allowed us to select a similar number of 
features within both the HS and LS environments. The 
application of the Permutation (Raw) method resulted 
in the selection of fewer features under HS compared 
to LS but remained reasonably sensitive, successfully 
selecting a number of HS stable features across all but 
the control vs stage 1 analyses. The RFE methods exhib-
ited a low sensitivity across all comparisons, identify-
ing a maximum of 14 LS feature but no HS features. 
Similarly, the Permutation (Raw) method identified a 
limited number of HS features and the second largest 
number of LS features, indicating a poor selection sta-
bility between iterations.
The second genomics data was reported by Qurai-
shi et al. [37] with the aim to identify differential genes 
between patients with PSC have colitis (PSC-IBD) vs. 
ulcerative colitis (UC). The analysis was conducted 
using the same framework and a total of 59 stable fea-
tures (Additional file 1, SF10) were identified. Out of 59 
genes that were identified, 15 genes were also reported 
by Quraishi et al. [37].
The third dataset resulted from a comprehensive 
lipidomic and transcriptomics study of white adipose 
tissue in mice that become obese either via a genetic 
modification (ob/ob) or diet (high fat diet) [38]. The 
genotype class:OB/OB type vs. wild type was consid-
ered as the outcome variable (Additional file  1, SF11). 
The application of the Boruta method allowed us to 
identify 101 stable features from the gene expression 
datasets.
The HS stable features, selected by the Boruta 
method, for each of the four analyses, formed the 
binary classification power functions (Module 2). For 
each case, these features were converted into correlated 
groups and the feature, from each group, with the larg-
est Cohen’s d effect size, was determined. In addition, 
for all cases, statistically significant differences, based 
on t-tests conducted for each feature, were observed 
between binary classes (Additional file 1, SF8).
The conducted power calculations determined the 
three features identified in the control vs stage one. 
Using these three features, a maximum power can 
be achieved using < 10 case samples. In other cases, 
the required number of samples vary from 5 to 1280 
(Additional file  1, SF9). In each comparison scenario, 
the effect size of all features was greater than the 1.0 
threshold [39].
Web tool
To streamline the power calculation estimation, we 
produced PowerTools, an interactive open-source web 
application, written in R code, using the Shiny frame-
work (http://shiny .rstud io.com/) (Fig. 5). The tool uses 
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different -omics types as input and performs efficient 
simulation-based power calculations for regression 
and classification analysis as well as for two-group clas-
sification. The web interface allows for a simple sam-
ple size specification as well as the visualization of the 
graphical output. The confusion matrix result values 
are presented as downloadable customisable plots as 
well as raw data tables. A user guide is provided in the 
Additional file 2.
Discussion
We have assessed the performance of four RF feature 
selection methods in the context of regression and classi-
fication, using both simulated and published experimen-
tal datasets. The known underlying correlation structure 
and relationship with the simulated data outcome vari-
able (y) was used for the method assessment in terms 
of the number of true and false positive features each 
method identified.
In the regression context, all methods were stable in 
their selection of true positive features within the HS 
environment, whereas the Boruta method alone main-
tained near perfect specificity within the LS environ-
ment. In contrast, the application of the Permutation 
(Raw) method resulted in the identification of an addi-
tional 98 false positive features with the LS environment 
in comparison to the ones identified within the HS one. 
These findings suggest that multiple iterations of fea-
ture selection, combined with a high stringency thresh-
old for stability, effectively eliminate any false positive 
features selected by these methods by chance. The high 
feature stability obtained by the Boruta method was 
characterised by the smallest difference in performance 
between stringency contexts, suggesting that its appli-
cation might be favoured in scenarios where the large 
computational runtime multiple iterations necessitate 
cannot be guaranteed.
When we applied RF based feature selection methods 
to publicly available data, it was impossible to distinguish 
variables truly associated with the outcome from false 
positives. Consequently, the subset of features, selected 
by each method, were assessed only in terms of their sta-
bility, numerosity and the predictive performance of their 
resultant validation models. Across the two published 
experimental datasets considered for regression, the 
Boruta method exhibited the best stability levels, produc-
ing the smallest difference in the number of the selected 
features between the different stringency states. In addi-
tion, the Boruta method identified the largest number 
of stable HS features across multiple datasets producing 
higher numbers of biomarker candidates [42].
The RFE method identified the smallest subset of HS 
stable features for every dataset that it was assessed 
against, a finding that was expected since the method 
is designed to identify the smallest subset of predictive 
features [27]. Consequently, the RFE method exhibited 
the worst stability, producing a 15-fold difference in the 
number HS/LS features identified for the metabolomics 
data set and an 11-fold difference for the lipidomics one. 
Recently, [43] discussed a heuristic method for the iden-
tification of biomarkers, termed RGIFE (Rank Guided 
Iterative Feature Elimination), which is a variant of the 
RFE method. RGIFE employs information, extracted 
from machine learning models, to ensure that the mini-
mal and highly predictive marker sets can be established.
In terms of classification, each method resulted in 
fewer stable feature selection for both the simulated and 
the experimental datasets. However, each of the method 
that was applied had a similar performance and the 
Boruta method exhibited the highest stability, across all 
Fig. 5 Screenshots of the open- source web application ‘PowerTools’, for efficient and accessible simulation based power calculations
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cases. The assessment of the methods’ performance over 
simulated data revealed that all methods were able to 
identify only true positive variables within the HS envi-
ronment, and the Permutation (Raw) method identified 
the highest number of true positive variables.
One of the limitation of the Boruta method lies with 
the time complexity associated with its performance 
when dealing with large high dimensional datasets. [26] 
For the case of the metabolomics dataset, the Boruta and 
Permutation (Raw) methods exhibited a similar stabil-
ity, while the Boruta method identified the largest num-
ber of biomarker candidates. For the case of the cancer 
transcriptomics dataset, Boruta exhibited a similar per-
formance between each pairwise comparison of controls 
and CRC stage. The Boruta method selected HS features 
across all four comparisons and exhibited a consistent 
selection behavior within the LS environment. RFE, on 
the other hand, exhibited the poorest stability in the case 
of the IBD and mice gene expression datasets, failing to 
select a single HS feature across them. Overall, however, 
across all experimental datasets that were assessed, our 
approach was successful in retrieving the majority of the 
known metabolites or genes indicating its potential for 
identifying important features that can facilitate potential 
novel biomarker discovery.
The assessment of the RF model’s performance across 
the different datasets revealed limited variation, a find-
ing which is supported by various previous studies [42, 
44]. The RF algorithm is capable of compensating for 
noisy features with limited model performance loss [44, 
45]. Furthermore, the variance in predictive performance 
values between CV repeats was greater when using vari-
ables selected within the HS environment (e.g. Fig.  2c). 
This effect can be understood with respect to the greater 
differences, between outer loop repeats, in the variables 
meeting the HS selection criteria, compared to the equiv-
alent differences in those which surpass the LS selection 
criteria.
One of the limitations of our approach lies with our 
focus on the use of feature solemnly selected by RF. Any 
classifier that can provide a ranking of feature’s impor-
tance would be suitable for our framework. RF, however, 
has been reported as being potential advantageous over 
other classification approaches. For example, Couronné 
et al., [46] used a large-scale benchmarking experiment, 
based on 243 experimental datasets, comparing the pre-
diction performance of the RF and logistic regression. 
They reported RF to perform better than logistic regres-
sion in terms of the accuracy measured (in approximately 
69% of the datasets). The use of RF over support vector 
machine (SVM) is also supported by several studies. For 
example, in a cancer related study [47], electronic tongue 
data classification RF [48]) was reported to have a con-
sistently good performance.
We sought to combine our stable feature selection 
protocol with a novel simulation-based approach to 
facilitate power calculations for the design of potential 
future studies. Further to previous efforts by [24], who 
compared the power achieved by a multitude of clas-
sifiers when presented with diverse sets of data, we 
focused on RF but expanded into both the classification 
and regression domains. Furthermore, we ensured that 
the true correlation structure of the input data was cap-
tured by applying a methodology originally used in the 
context of metabolic phenotyping [23]. We incorpo-
rated automated effect size calculations, and grouped 
similar variables before filtering them by effect size, to 
identify a small subgroup of high effect putative bio-
markers for which to quantify power.
We validated the performance of our power calcu-
lations with respect to the values achieved using the 
simulated regression data. The power values predicted 
for each feature matched the observed empirical power 
achieved by most stable feature selection methods 
(Additional file 1, SF2B). Furthermore, as expected, we 
consistently observed that smaller necessary sample 
sizes are required for features with larger effect val-
ues, An example of this effect is illustrated for the case 
of the CRC stage 3 data [36] (Additional file 1, SF9C), 
where the effect sizes ranged between 4.78 and 1.65, 
and the sample size necessary to obtain maximal power 
ranged from < 5 to > 1280. We also observed that the 
Boruta method, in terms of its prediction ability, exhib-
ited the best performance in contrast to the RFE which 
had the worst performance primarily due it selection of 
few features (Additional file 1, Table 1 and 2).
We explored a variety of sample sizes so as to identify 
the necessary ones to achieve good power, concluding 
that less than 40 samples is necessary to achieve max-
imum power with an effect size of 0.8 in a regression 
mode and no more than 10 samples is necessary, with 
a Cohen’s d effect of 3.0, in a classification mode. The 
effect sizes reported are consistent amongst the stable 
features selected by Boruta. For almost all the cases 
assessed, fewer samples were necessary to achieve max-
imum power for feature selection during classification 
than regression. This observation corroborates the high 
stringency observed for the classification mode feature 
selection in module one.
Lastly, we developed PowerTools, an interactive 
open-source web application, to facilitate the estima-
tion of the number of samples required for potential 
future studies and to cater the clustering of similar 
features determining the effect size associated with 
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potential biomarkers. While other power analysis tools 
exist, most have different functionality limitations, for 
example providing only raw functions [23, 49], relat-
ing only to specific study designs, such as case–control 
microbiome studies [50], or lacking support and fur-
ther development [24]. We believe that our workflow 
overcomes such limitations and is generalised across 
multiple different –omics datasets aiding the transla-
tional community’s efforts to interpret the stability of 
novel biomarkers and design potential future valida-
tions studies.
Conclusion
In this paper, we presented a number of different RF 
based stable feature selection methods and compared 
their performances using simulated as well as publicly 
available experimentally derived datasets. Across all of 
the scenarios considered, the application of the Boruta 
method formed the most stable approach, while the 
application of the Permutation (Raw) method, when 
allowed to be stabilised over a number of iterations, 
resulted in the identification of the largest number of 
relevant features. We determined that the decision over 
the approach selection should be weighed against the 
computational requirements and the runtime require-
ments. Finally, we have developed a web-based inter-
face that caters the calculation of the effect size of the 
stable biomarkers for potential future studies.
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